Tetsuya Sakashita Selected Research

Pheochromocytoma

9/2022	Organic cation transporter 3 mediates the non-norepinephrine transporter driven uptake of meta-[211At]astato-benzylguanidine.
1/2019	Anti-tumor effects and potential therapeutic response biomarkers in α-emitting meta-211At-astato-benzylguanidine therapy for malignant pheochromocytoma explored by RNA-sequencing.
1/2018	Antitumor effects of radionuclide treatment using α-emitting meta-211At-astato-benzylguanidine in a PC12 pheochromocytoma model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tetsuya Sakashita Research Topics

Disease

7	Neoplasms (Cancer) 09/2022 - 12/2006
3	Pheochromocytoma 09/2022 - 01/2018
2	Dehydration (Water Stress) 01/2018 - 11/2010
2	Chromosome Aberrations (Chromosome Abnormalities) 09/2015 - 02/2007
1	Kidney Neoplasms (Kidney Cancer) 09/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 09/2022
1	Neuroblastoma 01/2021
1	Weight Loss (Weight Reduction) 01/2018
1	Dysferlinopathy 01/2009
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 11/2008
1	Glioblastoma (Glioblastoma Multiforme) 08/2008

Drug/Important Bio-Agent (IBA)

3	IonsIBA 01/2018 - 02/2007
3	CarbonIBA 09/2015 - 08/2008
2	benzylguanidineIBA 09/2022 - 01/2021
2	3-Iodobenzylguanidine (Iobenguane)IBA 09/2022 - 02/2018
2	SolutionsIBA 09/2022 - 01/2018
2	Radioisotopes (Radionuclides)IBA 02/2018 - 01/2018
2	DNA (Deoxyribonucleic Acid)IBA 11/2010 - 02/2007
1	Phosphates (Orthophosphate)IBA 09/2022
1	Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA 09/2022
1	meta-((211)At)astatobenzylguanidineIBA 09/2022
1	Hydrocortisone (Cortisol)FDA LinkGeneric 09/2022
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	RNA (Ribonucleic Acid)IBA 01/2019
1	RadiopharmaceuticalsIBA 02/2018
1	Therapeutic UsesIBA 01/2018
1	1-(3-astatobenzyl)guanidineIBA 01/2018
1	BuffersIBA 01/2018
1	ArgonIBA 09/2015
1	ChromatinIBA 11/2010
1	Proteins (Proteins, Gene)FDA Link 01/2009
1	DysferlinIBA 01/2009
1	ethyl 2- amino- 6- bromo- 4- (1- cyano- 2- ethoxy- 2- oxoethyl)- 4H- chromene- 3- carboxylateIBA 11/2008
1	DNA-Activated Protein KinaseIBA 02/2007
1	lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA 02/2007
1	2- phenyl- 4,4,5,5- tetramethylimidazoline- 1- oxyl- 3- oxideIBA 02/2007
1	Conditioned Culture MediaIBA 02/2007

Therapy/Procedure

2	Therapeutics 01/2019 - 01/2018
1	Anesthesia 01/2018
1	Intravenous Injections 01/2018
1	Heavy Ion Radiotherapy 11/2008
1	Radiotherapy 12/2006